Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: A meta-analysis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Chen, Cai ^a   Yu, Xuefeng ^a   Shao, Shiying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INSULIN; LIPID; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; OMEGA 3 FATTY ACID;

ARTICLE; ASIAN; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADULT; BLOOD; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84947242025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139565     Document Type: Article

References (42)

1. American Diabetes A (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32 Suppl 1: S62-67. doi: 10.2337/dc09-S062 PMID: 19118289
2. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14. doi: 10.1016/j.diabres.2009.10.007 PMID: 19896746
3. Gubitosi-Klug RA, Group DER (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care 37: 44-49. doi: 10.2337/dc13-2148 PMID: 24356597
4. Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383: 1999-2007. doi: 10.1016/S0140-6736(14)60613-9 PMID: 24910231
5. American Diabetes A (2015) (4) Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization. Diabetes Care 38 Suppl: S20-30. doi: 10.2337/dc15-S007 PMID: 25537702
6. Sagild U, Littauer J, Jespersen CS, Andersen S (1966) Epidemiological studies in Greenland 1962-1964. I. Diabetes mellitus in Eskimos. Acta Med Scand 179: 29-39. PMID: 5904457
7. Bang HO, Dyerberg J, Sinclair HM (1980) The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33: 2657-2661. PMID: 7435433
8. Kromann N, Green A (1980) Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 208: 401-406. PMID: 7457208
9. Patel PS, Forouhi NG, Kuijsten A, Schulze MB, van Woudenbergh GJ, Ardanaz E, et al. (2012) The prospective association between total and type of fish intake and type 2 diabetes in 8 European countries: EPIC-InterAct Study. Am J Clin Nutr 95: 1445-1453. doi: 10.3945/ajcn.111.029314 PMID: 22572642
10. Zhou Y, Tian C, Jia C (2012) Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies. Br J Nutr 108: 408-417. doi: 10.1017/S0007114512002036 PMID: 22857650
11. Li D (2015) Omega-3 polyunsaturated fatty acids and non-communicable diseases: meta-analysis based systematic review. Asia Pac J Clin Nutr 24: 10-15. doi: 10.6133/apjcn.2015.24.1.21 PMID: 25740737
12. Muley A, Muley P, Shah M (2014) ALA, fatty fish or marine n-3 fatty acids for preventing DM?: a systematic review and meta-analysis. Curr Diabetes Rev 10: 158-165. PMID: 24828061
13. Wong CY, Yiu KH, Li SW, Lee S, Tam S, Lau CP, et al. (2010) Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus. Diabet Med 27: 54-60. doi: 10.1111/j.1464-5491.2009.02869.x PMID: 20121889
14. Pooya S, Jalali MD, Jazayery AD, Saedisomeolia A, Eshraghian MR, Toorang F (2010) The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 20: 326-331. doi: 10.1016/j.numecd.2009.04.002 PMID: 19540739
15. Neil HA, Ceglarek U, Thiery J, Paul S, Farmer A, Holman RR (2010) Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. Atherosclerosis 213: 512-517. doi: 10.1016/j. atherosclerosis.2010.09.013 PMID: 21036355
16. Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S (2008) Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Health J 14: 305-313. PMID: 18561722
17. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, et al. (2007) Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86: 1670-1679. PMID: 18065585
18. Sirtori CR, Paoletti R, Mancini M, Crepaldi G, Manzato E, Rivellese A, et al. (1997) N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study. Am J Clin Nutr 65: 1874-1881. PMID: 9174486
19. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, et al. (1996) Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19: 1207-1213. PMID: 8908381
20. Morgan WA, Raskin P, Rosenstock J (1995) A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Diabetes Care 18: 83-86. PMID: 7698053
21. Pelikanova T, Kohout M, Valek J, Kazdova L, Base J (1993) Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients. Ann N Y Acad Sci 683: 272-278. PMID: 8251021
22. Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, et al. (1998) Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21: 717-724. PMID: 9589230
23. McManus RM, Jumpson J, Finegood DT, Clandinin MT, Ryan EA (1996) A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 19: 463-467. PMID: 8732710
24. Puhakainen I, Ahola I, Yki-Jarvinen H (1995) Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 61: 121-126. PMID: 7825523
25. Schectman G, Kaul S, Kissebah AH (1988) Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37: 1567-1573. PMID: 3181646
26. Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, et al. (1991) A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87: 65-73. PMID: 1872925
27. Borkman M, Chisholm DJ, Furler SM, Storlien LH, Kraegen EW, Simons LA, et al. (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38: 1314-1319. PMID: 2676659
28. Glauber H, Wallace P, Griver K, Brechtel G (1988) Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108: 663-668. PMID: 3282462
29. Okuda Y, Mizutani M, Ogawa M, Sone H, Asano M, Asakura Y, et al. (1996) Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. J Diabetes Complications 10: 280-287. PMID: 8887017
30. Kasim SE, Stern B, Khilnani S, McLin P, Baciorowski S, Jen KL (1988) Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. J Clin Endocrinol Metab 67: 1-5. PMID: 3379125
31. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, van der Veen EA (1987) Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 4: 141-147. PMID: 3038454
32. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. (1993) Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 33-38. PMID: 8436250
33. Montori VM, Farmer A, Wollan PC, Dinneen SF (2000) Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23: 1407-1415. PMID: 10977042
34. Hartweg J, Farmer AJ, Holman RR, Neil A (2009) Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 20: 30-38. PMID: 19133409
35. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12. PMID: 8721797
36. Schulz KF, Chalmers I, Altman DG, Grimes DA, Dore CJ (1995) The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online J Curr Clin Trials Doc No 197: [81 paragraphs].
37. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. PMID: 9310563
38. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, et al. (2013) Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38: 1154-1163. doi: 10.1016/j.immuni.2013.05.015 PMID: 23809162
39. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Morán-Salvador E, et al. (2009) Obesityinduced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23: 1946-1957. doi: 10.1096/fj.08-125674 PMID: 19211925
40. Molinar-Toribio E, Perez-Jimenez J, Ramos-Romero S, Romeu M, Giralt M, Taltavull N, et al. (2015) Effect of n-3 PUFA supplementation at different EPA:DHA ratios on the spontaneously hypertensive obese rat model of the metabolic syndrome. Br J Nutr 113: 878-887. doi: 10.1017/S0007114514004437 PMID: 25720761
41. Zheng JS, Huang T, Yang J, Fu YQ, Li D (2012) Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One 7: e44525. doi: 10.1371/journal.pone.0044525 PMID: 22984522
42. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A (2012) Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 35: 918-929. doi: 10.2337/dc11-1631 PMID: 22442397